Hepatic fibronectin matrix turnover in rats: Involvement of the asialoglycoprotein receptor

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 277, Issue 6 40-6, 1999, Pages

  Rotundo, Robert F ^a   Vincent, Peter A ^a   Mckeown Longo, Paula J ^a   Blumenstock, Frank A ^a   Saba, Thomas M ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Extracellular matrix proteins; Galactose; Hepatocyte receptors; Liver

Indexed keywords

ASIALOGLYCOPROTEIN RECEPTOR; FIBRONECTIN; SCLEROPROTEIN;

ANIMAL TISSUE; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOWN REGULATION; ENDOCYTOSIS; EXTRACELLULAR MATRIX; LIVER; MALE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; RAT;

EID: 0033385965     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1999.277.6.g1189     Document Type: Article

References (55)

1. Allio, A. E., and P. J. McKeown-Longo. Extracellular matrix assembly of cell-derived and plasma-derived fibronectins by substrate-attached fibroblasts. J. Cell. Physiol. 135: 459-466, 1988.
2. Ashwell, G., and J. Harford. Carbohydrate-specific receptors of the liver. Annu. Rev. Biochem. 51: 531-554, 1982.
3. Ashwell, G., and A. G. Morell. The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv. Enzymol. Relat. Areas Mol. Biol. 41: 99-128, 1974.
4. Ballardini, G., A. Faccani, M. Fallani, S. Berti, V. Vasi, C. Castaldini, G. Biagini, S. Garbisa, and F. B. Bianchi. Sequential behaviour of extracellular matrix glycoproteins in an experimental model of hepatic fibrosis. Virchows Arch. 49: 317-324, 1985.
5. Cenacchi, B., G. Ballardini, L. Badiali De Giorgi, C. A. Busachi, M. Del Rosso, F. B. Bianchi, G. Biagini, and R. Laschi. Relationship between connective tissue cells and fibronectin in a sequential model of experimental hepatic fibrosis. Virchows Arch. 43: 75-84, 1983.
6. Charash, W. E., P. A. Vincent, P. J. McKeown-Longo, T. M. Saba, E. Lewis, and M. A. Lewis. Kinetics of plasma fibronectin: increased lung tissue incorporation after postoperative bacteremia. Am. J. Physiol. 260 (Regulatory Integrative Comp. Physiol. 29): R553-R562, 1991.
7. Charash, W. E., P. A. Vincent, T. M. Saba, F. L. Minnear, P. J. McKeown-Longo, J. A. Migliozzi, M. A. Lewis, E. Lewis, and C. Guinta. Immunofluorescent analysis of plasma fibronectin incorporation into the lung during acute inflammatory vascular injury. Am. Rev. Respir. Dis. 148: 467-476, 1993.
8. Decker, K., and D. Keppler. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev. Physiol. Biochem. Pharmacol. 71: 78-106, 1974.
9. Decker, K., D. Keppler, and J. Pausch. The regulation of pyrimidine nucleotide level and its role in experimental hepatitis Adv. Enzyme Regul. 11: 205-230, 1973.
10. Deno, D. C., T. M. Saba, and E. P. Lewis. Kinetics of endogenously labeled plasma fibronectin: incorporation into tissues. Am. J. Physiol. 245 (Regulatory Integrative Comp. Physiol. 14): R564-R575, 1983.
11. El-Mofty, S. K., M.C. Scrutton, A. Serroni, C. Nicolini, and J. L. Farber. Early, reversible plasma membrane injury in galactosamine-induced liver cell death. Am. J. Pathol. 79: 579-596, 1975.
12. Farber, G. A. L., G. Gill, and Y. Konishi. Prevention of galactosamine-induced liver cell necrosis by uridine. Am. J. Pathol. 72: 53-62, 1973.
13. Hughes, R. C., and S. C. Stamatoglou. Adhesive interactions and the metabolic activity of hepatocytes. J. Cell Sci. Suppl. 8: 273-291, 1987.
14. Hynes, R. O. Fibronectins. New York: Springer-Verlag, 1990.
15. Iredale, J. P., and M. J. P. Arthur. Hepatocyte matrix interactions. Gut 35: 729-732, 1994.
16. Irie, S., and M. Tavassoli. Liver endothelium desialates ceruloplasmin. Biochem. Biophys. Res. Commun. 140: 94-99, 1986.
17. Jin, H. M., P. A. Vincent, W. E. Charash, T. M. Saba, P. McKeown-Longo, F.A. Blumenstock, and E. Lewis. Incorporation of circulating fibronectin into various tissues during sepsis: colocalization with endogenous tissue fibronectin. Exp. Mol. Pathol. 55: 203-216, 1991.
18. Jonker, A. M., F. W. J. Dijkhuis, A. Boes, M. J. Hardonk, and J. Grond. Immunohistochemical study of extracellular matrix in acute galactosamine hepatitis in rats. Hepatology 15: 423-431, 1992.
19. Jonker, A. M., W. J. Dijkhuis, M. J. Hardonk, P. Moerkerk, J. T. Kate, and J. Grond. Immunohistochemical study of hepatic fibrosis induced in rats by multiple galactosamine injections. Hepatology 19: 775-781, 1994.
20. Keppler, D. O. R., J. F. M. Rudigier, E. Bischoff, and F. A. Decker. The trapping of uridine phosphates by D-galactosamine, D-glucosamine and 2-deoxy-D-galactose. A study on the mechanism of galactose-amine hepatitis. Eur. J. Biochem. 17: 246-253, 1970.
21. Loreal, O., F. Levavasseur, C. Fromaget, D. Gros, A. Guillouzo, and B. Clement. Cooperation of Ito cells and hepatocytes in the deposition of an extracellular matrix in vitro. Am. J. Pathol. 143: 538-544, 1993.
22. Martinez-Hernandez, A. The hepatic extracellular matrix. I. Electron immuno-histochemical studies in normal rat liver. Lab. Invest. 51: 57-74, 1984.
23. Martinez-Hernandez, A., F. M. Delgado, and P. S. Amenta. The extracellular matrix in hepatic regeneration: localization of collagen types I, III, IV, laminin and fibronectin. Lab. Invest. 64: 157-166, 1991.
24. McKeown-Longo, P. J., and D. F. Mosher. Binding of plasma flbronectin to cell layers of human skin fibroblasts. J. Cell Biol. 97: 466-472, 1983.
25. McKeown-Longo, P. J., and D. F. Mosher. Mechanism of formation of disulflde-bonded multimers of plasma fibronectin in cell layers of cultured human fibroblasts. J. Biol. Chem. 259: 12210-12215, 1984.
26. McKeown-Longo, P. J., and D. F. Mosher. Interaction of the 70,000-mol-wt amino-terminal fragment of fibronectin with the matrix-assembly receptor of fibroblasts. J. Cell Biol. 100: 364-374, 1985.
27. Mosher, D. F. Fibronectin. Prog. Hemost. Thromb. 5: 111-151, 1980.
28. Oh, E., M. Pierschbacher, and E. Ruoslahti. Deposition of plasma fibronectin in tissues. Proc. Natl. Acad. Sci. USA 78: 3218-3221, 1981.
29. Pande, H., J. Corkill, R. Sailor, and J. E. Shively. Comparative structural studies of human plasma and amniotic fibronectin. Biochem. Biophys. Res. Commun. 101: 265-272, 1981.
30. Pardridge, W. M., A. J. Van Herle, R. T. Naruse, G. Fierer, and A. Costin. In vivo quantification of receptor-mediated uptake of asialogylocprotein by rat liver. J. Biol. Chem. 258: 990-994, 1983.
31. Petovka, D. H., A. B. Momchilova, T. T. Markovska, and K. S. Koumanov. D-Galactosamine induced changes in rat liver plasma membranes lipid composition and some enzyme activities. Int. J. Biochem. 19: 289-291, 1987.
32. Pricer, W. E., Jr., R. L. Hudgin, G. Ashwell, R. J. Stockert, and A. G. Morell. A membrane receptor protein for asialoglycoproteins. Methods Enzymol. 34: 688-691, 1974.
33. Rasenack, J., H. K. Koch, J. Nowack, R. Lesch, and K. Decker. Hepatotoxicity of D-galactosamine in the isolated perfused rat liver. Exp. Mol. Pathol. 32: 264-275, 1980.
34. Rebres, R. A., E. Cho, R. F. Rotundo, and T. M. Saba. Reduced in vivo plasma fibronectin content of lung matrix during postoperative sepsis. Am. J. Physiol. 271 (Lung Cell. Mol. Physiol. 15): L409-L418, 1996.
35. Rebres, R. A., P. J. McKeown-Longo, P. A. Vincent, E. Cho, and T. M. Saba. Extracellular matrix incorporation of normal and NEM-alkylated fibronectin: liver and spleen deposition. Am. J. Physiol. 269 (Gastrointest. Liver Physiol. 32): G902-G912, 1995.
36. Rotundo, R. F., R. A. Rebres, P. J. McKeown-Longo, F. A. Blumenstock, and T. M. Saba. Circulating cellular fibronectin may be a natural ligand for the hepatic asialoglycoprotein receptor: possible pathway for fibronectin deposition and turnover in the rat liver. Hepatology 28: 475-485, 1998.
37. Saba, T. M. Plasma fibronectin and hepatic Kupffer cell function. In: Progress in Liver Disease, edited by H. Popper and F. Schaffner. New York: Grune & Stratton, 1982, p. 109-131.
38. Saba, T. M. Fibronectin: role in phagocytic host defenses and lung vascular integrity. In: Fibronectin in Health and Disease, edited by S. Carsons. Boca Raton, FL: CRC, 1989, p. 49-68.
39. Sawamura, T., S. Kawasato, Y. Shiozaki, Y. Sameshima, H. Nakada, and Y. Tashiro. Decrease of hepatic binding protein specific for asialoglycoproteins with accumulation of serum asialoglycoproteins in galactosamine-treated rats. Gastroenterology 81: 527-533, 1981.
40. Schwartz, A. L. The hepatic asialoglycoprotein receptor. CRC Crit. Rev. Biochem. 16: 207-233, 1995.
41. Stamatoglou, S. C., R.-C. Ge, G. Mills, T. D. Butters, F. Zaidi, and R. C. Hughes. Identification of a novel glycoprotein (AGp110) involved in interactions of rat liver parenchymal cells with fibronectin. J. Cell Biol. 111: 2117-2127, 1990.
42. Stamatoglou, S. C., K. H. Sullivan, S. Johansson, P. M. Bayley, I. D. Burdett, and R. C. Hughes. Localization of two fibronectin-binding glycoproteins in rat liver and primary hepatocytes. J. Cell Sci. 97: 595-606, 1990.
43. Sudhakaran, P. R., S. Stamatoglou, and R. C. Hughes. Modulation of protein synthesis and secretion by substratum in primary cultures of rat hepatocytes. Exp. Cell Res. 167: 505-516, 1986.
44. Sweeley, C. C. Extracellular sialidases. Adv. Lipid Res. 26: 235-252, 1993.
45. Takasaki, S., K. Yamashita, K. Suzuki, and A. Kobata. Structural studies of the sugar chains of cold-insoluble globulin isolated from human plasma. J. Biochem. (Tokyo) 88: 1587-1594, 1980.
46. Tavassoli, M. The role of liver endothelium in the transfer of iron from transferrin to the hepatocyte. Ann. NY Acad. Sci. 526: 83-92, 1988.
47. Tavassoli, M., T. Kishimoto, and M. Kataoka. Liver endothelium mediates the hepatocyte's uptake of ceruloplasmin. J. Cell Biol. 102: 1298-1303, 1986.
48. Thompson, C., F. A. Blumenstock, T. M. Saba, P. J. Feustel, J. E. Kaplan, J. B. Fortune, L. Hough, and V. Gray. Plasma fibronectin synthesis in normal and injured humans as determined by stable isotope incorporation. J. Clin. Invest. 84: 1226-1235, 1989.
49. Toth, C. A., and P. Thomas. Liver endocytosis and Kupfer cells. Hepatology 16: 255-266, 1992.
50. Turner, G. A. N-glycosylation of serum proteins in disease and its investigation using lectins. Clin. Chim. Acta 208: 149-171, 1992.
51. Vincent, P. A., T. M. Saba, E. Lewis, and E. Cho. Contribution of hepatic fibronectin synthesis to regulation of plasma fibronectin. Am. J. Physiol. 257 (Regulatory Integrative Comp. Physiol. 26): R1406-R1416, 1989.
52. Wheatley, E. M., P. J. McKeown-Longo, P. A. Vincent, and T. M. Saba. Incorporation of fibronectin into matrix decreases TNF-induced increase in endothelial monolayer permeability. Am. J. Physiol. 265 (Lung Cell. Mol. Phvsiol. 9): L148-L157, 1993.
53. Wheatley, E. M., P. A. Vincent, P. J. McKeown-Longo, and T. M. Saba. Effect of fibronectin on permeability of normal and TNF-treated lung endothelial cell monolayers. Am. J. Physiol. 264 (Regulatory Integrative Comp. Physiol. 33): R90-R96, 1993.
54. Winkler, J. R., and H. L. Segal. Swainsonine inhibits glycoprotein degradation by isolated rat liver lysosomes. J. Biol. Chem. 259: 15369-15372, 1984.
55. Wrann, M. Methylation analysis of the carbohydrate portion of fibronectin isolated from human plasma. Biochem. Biophys. Res. Commun. 84: 269-274, 1978.